In vitro and in vivo models for anti-amyloidosis nanomedicines-Reference-Cited by-同舟云学术

In vitro and in vivo models for anti-amyloidosis nanomedicines

Published:2021 Issue:2 Volume:6 Page:95-119
ISSN:2055-6756
Container-title:Nanoscale Horizons
language:en
Short-container-title:Nanoscale Horiz.

Author:

Kakinen Aleksandr¹²³⁴^ORCID,Javed Ibrahim¹²³⁴^ORCID,Davis Thomas P.¹²³⁴⁵^ORCID,Ke Pu Chun¹²³⁴⁵^ORCID

Affiliation:

1. Australian Institute for Bioengineering and Nanotechnology

2. The University of Queensland

3. Brisbane

4. Australia

5. ARC Centre of Excellence in Convergent Bio-Nano Science and Technology

Abstract

Impactful research in nanomedicine depends upon the adequate use of cellular and animal models. Here we systematically review and evaluate the in vitro and in vivo models which have enabled the development of anti-amyloidosis nanomedicines.

Funder

Australian Research Council

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2021/NH/D0NH00548G

Reference160 articles.

1. Atomic structures of amyloid cross-β spines reveal varied steric zippers

2. Oligomeric amyloid associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques

3. A new era for understanding amyloid structures and disease

4. Proliferation of amyloid- 42 aggregates occurs through a secondary nucleation mechanism

5. The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering nanoprobes for magnetic resonance imaging of brain diseases;Chemical Engineering Journal;2024-02

2. Spike Protein Fragments Promote Alzheimer’s Amyloidogenesis;ACS Applied Materials & Interfaces;2023-08-16

3. Vector enabled CRISPR gene editing – A revolutionary strategy for targeting the diversity of brain pathologies;Coordination Chemistry Reviews;2023-07

4. The Ethnopharmacological Properties of Green-Engineered Metallic Nanoparticles against Metabolic Disorders;Medicina;2023-05-25

5. Therapeutic Potential of Nanomedicine in Management of Alzheimer’s Disease and Glioma;International Journal of Nanomedicine;2023-05